期刊文献+

临床试验信息化平台建设 被引量:5

Construction of clinical trial information platform
下载PDF
导出
摘要 我国的医药行业快速发展,近年来,越来越多的国际多中心临床试验也开始在我国进行,借助信息管理系统建设,药物临床试验成本不断降低、受试者招募效率高、医药市场增长快,可见我国在临床试验领域的发展潜力正在不断增大,医药研究和临床用药水平都在大幅度提升。本文主要介绍了临床试验信息化平台建设工作的基本目标和我院在这方面的发展现状,分析临床试验信息化平台建设的有效实现路径。 The pharmaceutical industry of our country is also developing rapidly,in recent years,more and more international multicenter clinical trials have also begun to be carried out in China.With the help of the construction of information management system,the cost of drug clinical trials has been continuously reduced,the recruitment efficiency of subjects is high,and the pharmaceutical market is growing rapidly.It can be seen that the development potential of our country in the field of clinical trials is increasing,and the level of medical research and clinical drug use is greatly improved.This paper mainly introduces the basic objectives of the construction of clinical trial information platform and the development status of our hospital in this respect,and analyzes the effective realization path of clinical experiment information platform construction.
作者 江丽华 黄嘉利 关灵 韩欣良 JIANG Li-hua;HUANG Jia-li;GUAN Ling(Dongguan people's hospital hospital drug clinical trial agency office,Guangdong 523000,China.)
出处 《中国处方药》 2020年第1期41-43,共3页 Journal of China Prescription Drug
基金 东莞市社会科技发展(一般)项目(201850725001342)
关键词 临床试验 信息化 平台建设 数据管理系统 Clinical trial Informatization Platform construction Data management system
  • 相关文献

参考文献8

二级参考文献64

  • 1国家食品药品监督管理局.药物临床试验机构资格认定办法(试行)[EB/OL].[2004-02-19].http://www.sdmgov.cn/WS01/CL00S8/9346.html.
  • 2国家药品安全"十二五"规划.专栏五:国家药品监管信息系统二期工程[Z].
  • 3国家食品药品监督管理局.药物』临床试验质量管理规范[EB/OL].(2003-08-06)[2015-11-08].http://www.sda.gov.cn/WS01/CL0053,24473.html.
  • 4FDA. FDA adverse events reporting system (FAERS) electronic submissions [EB/OL]. (2004-02-19) [2015-11-08].http ://www. fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveil - lance/AdverseDrugEffects/ucml 15894.htm.
  • 5FDA. IRB continuing review after clinical investigation approval [EB/OL]. (2010 -09 -21 ) [2015 -11 -08].http ://www.fda.gov/ ScienceResearch/SpecialTopics/RuuningClinicalTrials/ucm226306. htm.
  • 6ICH. Electronic standards for the transfer of regulatory information (ESTRI) [EB/OL]. (2010-06-24)[2015-11-08].http://www.ich. org/product~/guidelines/muhidisciplinary/article/multidisci-plinary- guidelines.html.
  • 7高茹英,张红莲,任蔚.我国科研经费投入中存在的问题及对策[J].研究与发展管理,2008,20(6):125-130. 被引量:26
  • 8王天勋,韩涓.国际多中心临床试验在中[J].上海食品药品监管情报研究,2009(2):1-5. 被引量:9
  • 9鲁瑞萍,刘玉,侯月梅.医院伦理委员会建设探讨[J].中国医学伦理学,2011,24(2):255-256. 被引量:8
  • 10吴建元,邹晓沨,黄建英.机构办公室加强药物临床试验规范化管理探讨[J].中华医学科研管理杂志,2011,24(2):86-89. 被引量:13

共引文献113

同被引文献71

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部